AzTrials
AzTrials

Weight LossNCT07535892

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

A study testing Weight Loss Maintenance Program (Foundational), Mom's Meals and YMCA Membership in people with Weight Loss and GLP - 1, run by University of Alabama at Birmingham at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a single-site, pilot randomized factorial trial designed to evaluate the feasibility, acceptability, participant perceptions and preliminary effects of a multi-component behavioral intervention to support weight loss maintenance following discontinuation of GLP-1 and other anti-obesity medications. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Weight Loss, GLP - 1, Weight Loss Maintenance
What is being tested?
Weight Loss Maintenance Program (Foundational), Mom's Meals and YMCA Membership
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteUnited States
Study dates
1 Nov 2026to 31 Jul 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Loss of ≥15% of initial body weight using anti-obesity medication
  • Discontinued anti-obesity medication within the past 4 weeks or planning to discontinue prior to randomization
  • ≤3 kg weight regain within the past 3 months
  • Willing and able to participate in a 6-month behavioral intervention, including a 10-week foundational program
  • Willing to complete study assessments at baseline, 3 months, and 6 months, including required in-person visits
Show all 10Show fewer
  • Medical clearance for participation in moderate physical activity, dietary modification, and mind-based practices
  • Access to reliable internet for participation in virtual sessions and remote data collection
  • English fluency sufficient to complete study procedures
  • Able to provide informed consent

Who cannot join

  • Medical conditions that would preclude safe participation in physical activity, dietary changes, or mind-based practices (e.g., unstable cardiovascular disease, uncontrolled hypertension, severe orthopedic limitations, or seizure disorders not medically managed)
  • Active psychiatric conditions that would interfere with participation or safety (e.g., untreated major depression, active substance use disorder, or psychosis)
  • Pregnancy, breastfeeding, or plans to become pregnant during the study period
  • Current participation in another structured weight loss or weight maintenance program
  • Continued use of anti-obesity medication after randomization
  • Plans to initiate medications or treatments that may significantly affect body weight during the study period
  • Inability to attend required study visits or participate in virtual sessions and remote data collection
  • Any condition that, in the opinion of the investigators, would compromise participant safety or study integrity

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Holly Wyatt, MD contact

303-378-6720

drholly@uab.edu

United States1 site
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294

    Holly Wyatt, MD, 205-975-6270, drholly@uab.edu

    Holly Wyatt, MD

Other trials in United States

About this study

Official title: Pilot Trial of a Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

This study is a single-site, pilot randomized factorial trial designed to evaluate the feasibility, acceptability, participant perceptions and preliminary effects of a multi-component behavioral intervention to support weight loss maintenance following discontinuation of GLP-1 and other anti-obesity medications. The intervention includes a standardized 10-week foundational weight loss maintenance program combined with candidate support components, including medically tailored meals, YMCA membership, and a structured mind-based program. Participants will be randomized using a 2 × 2 × 2 factorial design and followed for six months. Findings from this pilot study will inform optimization of a scalable intervention for future clinical trials.

Being tested
Weight Loss Maintenance Program (Foundational), Mom's Meals, YMCA Membership, SKY Meditation Program
Keywords
Weight Loss, GLP-1, Anti-Obesity Medication, weight loss maintenance
Medical subject headings
Weight Loss, Obesity, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Weight Loss Maintenance Program (Foundational)Behavioural

    All participants will receive a standardized 10-week foundational weight loss maintenance program designed to address three key domains: food, physical activity, and mind-based practices. This foundational program is intended to support the transition from active weight loss to long-term weight maintenance.

  • Mom's MealsBehavioural

    Medically tailored meals

  • YMCA MembershipBehavioural

    YMCA membership to support physical activity

  • SKY Meditation ProgramBehavioural

    The SKY Meditation program to support mind-based practices

Study groups in NCT07535892
Study groupRoleWhat they receive
Group 1: WLM Program + Mom's Meals + YMCA + SKYActive comparatorEight participants will be assigned to the foundational WLM program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive three candidate support components: (1) medically tailored meals (Mom's Meals), (2) YMCA membership to support physical activity, and (3) the SKY Meditation program to support mind-based practices.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: Mom's Meals; Behavioral: YMCA Membership; Behavioral: SKY Meditation Program
Group 2: WLM Program + Mom's Meals + YMCAActive comparatorEight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive two candidate support components: (1) medically tailored meals (Mom's Meals), (2) YMCA membership to support physical activity.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: Mom's Meals; Behavioral: YMCA Membership
Group 3: WLM Program + Mom's Meals + SKYActive comparatorEight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive candidate support components: (1) medically tailored meals (Mom's Meals), and (3) the SKY Meditation program to support mind-based practices.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: Mom's Meals; Behavioral: SKY Meditation Program
Group 4: WLM Program + Mom's MealsActive comparatorEight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive candidate support components: (1) medically tailored meals (Mom's Meals).
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: Mom's Meals
Group 5: WLM Program + YMCA + SKYActive comparatorEight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive candidate support components: (2) YMCA membership to support physical activity, and (3) the SKY Meditation program to support mind-based practices.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: YMCA Membership; Behavioral: SKY Meditation Program
Group 6: WLM Program + YMCAActive comparatorEight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive support components: (2) YMCA membership to support physical activity.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: YMCA Membership
Group 7: WLM Program + SKYActive comparatorEight Participants will be assigned to the foundational program, participants will be randomized using a full factorial 2 × 2 × 2 design to receive support components: (3) the SKY Meditation program to support mind-based practices.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational); Behavioral: SKY Meditation Program
Group 8: Foundational WLM Program OnlyActive comparatorEight participants will receive the 10-week foundational program. One group (n=8) will receive only the foundational program without any additional components.
Receives: Behavioral: Weight Loss Maintenance Program (Foundational)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of participants retention

    Retention will be calculated as the proportion of randomized participants completing the 3- and 6-month follow-up assessments. For the proposed study, retention rates ≥80% over the 6-month intervention period would indicate the study is feasible as-is. If retention is <80%, we will consider modifications to the study design and dedication of greater resources towards improving retention in the full-scale factorial trial.

    Measured: 3 months, 6 months,

  2. Percentage of participants that adhered to the 10-week foundational support sessions

    Adherence to the 10-week foundational support sessions will be measured as the percentage of attended sessions relative to scheduled sessions. For the proposed study, the feasibility benchmark for adherence was set at ≥80% attendance. If adherence is <80%, we will consider modifications to the study design and dedication of greater resources towards improving adherence in the full-scale factorial trial. The other measures of adherence will be evaluated with descriptive statistics. Completion rates of weekly logs for food intake, physical activity, and mind-based practices will be documented and tracked in REDCap. Additionally, daily usage of Garmin scales and fitness trackers will be monitored, with rates of adherence assessed as the percentage of days that participants engage with these devices.

    Measured: 10 weeks

Secondary outcomes (1)
  1. Overall Weight Loss Maintenance without medication

    Participants will be weighed at Baseline, 3 month, and 6 month intervals to see if they have maintained their overall weight loss.

    Measured: Baseline, 3 months, 6 moths

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion30 Apr 2029 (estimated)
  4. Study completion31 Jul 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
Participants will be randomized using a 2 × 2 × 2 factorial design and followed for six months. Findings from this pilot study will inform optimization of a scalable intervention for future clinical trials.
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07535892
Sponsor's protocol ID
IRB-300016552
Other IDs
1R01DK147319-01
Status last verified
Jun 2026
First submitted
10 Apr 2026
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: At the time of publication(s) related to this trial, a fully de-identified dataset including participant data will be made available so that data analysis can be replicated by other investigators. This dataset will be freely available for download as supplemental materials to manuscripts(s) submitted to PubMed Central.

Questions about this trial

What is this clinical trial studying?

A study testing Weight Loss Maintenance Program (Foundational), Mom's Meals and YMCA Membership in people with Weight Loss and GLP - 1, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Holly Wyatt, MD (303-378-6720, drholly@uab.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of participants retention (time frame: 3 months, 6 months,). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in